Justin R. Harrison
Dow Street
Dundee, SCT DD15EH, United Kingdom
Dundee, SCT DD15EH, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Identification of a Series Containing a Pentafluorophenyl Moiety That Targets Pks13 to Inhibit Growth of Mycobacterium tuberculosis.
Journal: ACS infectious diseases
Published: February 27, 2025
Repositioning of a Diaminothiazole Series Confirmed to Target the Cyclin-Dependent Kinase CRK12 for Use in the Treatment of African Animal Trypanosomiasis.
Journal: Journal of medicinal chemistry
Published: March 18, 2022
Discovery and Optimization of a Compound Series Active against Trypanosoma cruzi, the Causative Agent of Chagas Disease.
Journal: Journal of medicinal chemistry
Published: March 06, 2020
PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis.
Journal: Science (New York, N.Y.)
Published: October 09, 2018
A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors.
Journal: Journal of medicinal chemistry
Published: September 13, 2018
Validation of N-myristoyltransferase as Potential Chemotherapeutic Target in Mammal-Dwelling Stages of Trypanosoma cruzi.
Journal: PLoS neglected tropical diseases
Published: November 18, 2015
N-myristoyltransferase is a cell wall target in Aspergillus fumigatus.
Journal: ACS chemical biology
Published: February 24, 2015
Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis.
Journal: Journal of medicinal chemistry
Published: November 21, 2014
Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors.
Journal: Journal of medicinal chemistry
Published: December 14, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026